increased heart rate on semaglutide 2.4 mg delivered a statistically significant 20% risk reduction in major adverse cardiovascular events – REGENHEALTHSOLUTIONS (RHS) Wegovy® for Cardiovascular Risk |

every moms experience is unique, including yours

#diabetes #diabetesmanagement To view or add a comment, sign in BREAKING One Pill Just Changed The Game For 20 Million Americans With High Cholesterol A new drug called enlicitide just delivered results that could reshape how we treat cardiovascular disease

GLP-1 helps regulate blood sugar by stimulating insulin release and slowing stomach emptying, which keeps you feeling full longer

As a result, you may need to be asking for these tests and read posts like this to evaluate your lab result

Individual outcomes may vary based on adherence, lifestyle, and provider guidance

Should I tell my GP about anxiety before starting GLP-1 treatment